Research on Ostarine has focused on its ability to selectively bind to androgen receptors in muscle and bone tissues, aiming to promote muscle growth and improve bone density. Early studies in both animals and humans suggested that Ostarine had anabolic effects without many of the adverse effects typically associated with anabolic steroids, such as prostate enlargement or excessive hair growth.

Ostarine was also being investigated for its potential use in preventing muscle wasting in cancer patients and improving physical function in individuals with muscle-wasting conditions.

However, as with other SARMs, the research on Ostarine is still in its early stages. While initial studies showed promise in terms of its potential benefits and fewer side effects compared to traditional steroids, there’s limited data on its long-term safety and efficacy in humans.

Regulatory agencies have raised concerns about the marketing and sale of SARMs like Ostarine, as they are often sold as dietary supplements despite not being approved for human use and lacking comprehensive safety data. As a result, there are regulatory and legal implications surrounding its distribution and usage.

It’s crucial to approach the use of Ostarine or any similar compound with caution. Consulting a healthcare professional before considering its use is highly recommended to understand the potential risks, legality, and lack of comprehensive research on its safety and efficacy.